RedHill Covid-19 candidate found to lower ARDS-related blood clotting
The preclinical study analysed 250mg/kg of opaganib to measure thrombotic risks. Credit: PIRO4D from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
